Published in JAMA on July 19, 2006
Migraine headache in middle age and late-life brain infarcts. JAMA (2009) 2.65
Migraine and risk of haemorrhagic stroke in women: prospective cohort study. BMJ (2010) 2.63
Migraine and cardiovascular disease: a population-based study. Neurology (2010) 2.51
Migraine, vascular risk, and cardiovascular events in women: prospective cohort study. BMJ (2008) 2.48
Migraine frequency and risk of cardiovascular disease in women. Neurology (2009) 2.47
Migraine and mortality: a systematic review and meta-analysis. Cephalalgia (2011) 2.18
Migraine, migraine aura, and cervical artery dissection: a systematic review and meta-analysis. Cephalalgia (2011) 2.07
Migraine with aura and risk of cardiovascular and all cause mortality in men and women: prospective cohort study. BMJ (2010) 1.92
Agreement of self-reported migraine with ICHD-II criteria in the Women's Health Study. Cephalalgia (2009) 1.77
Migraine and risk of perioperative ischemic stroke and hospital readmission: hospital based registry study. BMJ (2017) 1.73
Body mass index, migraine, migraine frequency and migraine features in women. Cephalalgia (2009) 1.69
Migraine, weight gain and the risk of becoming overweight and obese: a prospective cohort study. Cephalalgia (2012) 1.55
Selectivity in genetic association with sub-classified migraine in women. PLoS Genet (2014) 1.54
Headache, migraine, and structural brain lesions and function: population based Epidemiology of Vascular Ageing-MRI study. BMJ (2011) 1.51
Migraine and cognitive decline: a topical review. Headache (2013) 1.48
Age-specific association of migraine with cryptogenic TIA and stroke: Population-based study. Neurology (2015) 1.42
Interrelationships among the MTHFR 677C>T polymorphism, migraine, and cardiovascular disease. Neurology (2008) 1.41
Migraine in women: the role of hormones and their impact on vascular diseases. J Headache Pain (2012) 1.40
Vascular risk factors, cardiovascular disease, and restless legs syndrome in men. Am J Med (2013) 1.23
MTHFR 677C>T and ACE D/I polymorphisms in migraine: a systematic review and meta-analysis. Headache (2009) 1.22
Advanced neuroimaging of migraine. Lancet Neurol (2009) 1.19
Body mass index and adult weight gain among reproductive age women with migraine. Headache (2011) 1.17
Alcohol and migraine: trigger factor, consumption, mechanisms. A review. J Headache Pain (2008) 1.16
Migraine and cardiovascular disease: possible mechanisms of interaction. Neurology (2009) 1.14
Interictal alterations of the trigeminal somatosensory pathway and periaqueductal gray matter in migraine. Neuroreport (2007) 1.13
The brain's heart - therapeutic opportunities for patent foramen ovale (PFO) and neurovascular disease. Pharmacol Ther (2013) 1.07
Comorbidities of migraine. Front Neurol (2010) 1.05
Comorbid neuropathologies in migraine: an update on cerebrovascular and cardiovascular aspects. J Headache Pain (2008) 1.05
Migraines during pregnancy linked to stroke and vascular diseases: US population based case-control study. BMJ (2009) 1.04
New insights into the cardiovascular risk of migraine and the role of white matter hyperintensities: is gold all that glitters? J Headache Pain (2013) 1.02
Reference programme: diagnosis and treatment of headache disorders and facial pain. Danish Headache Society, 2nd Edition, 2012. J Headache Pain (2012) 1.02
Migraine and restless legs syndrome in women. Cephalalgia (2012) 1.01
Migraine and functional outcome from ischemic cerebral events in women. Circulation (2010) 0.99
C-reactive protein in migraine sufferers similar to that of non-migraineurs: the Reykjavik Study. Cephalalgia (2009) 0.96
Relation of candidate genes that encode for endothelial function to migraine and stroke: the Stroke Prevention in Young Women study. Stroke (2009) 0.95
Comorbidity profiles of chronic migraine sufferers in a national database in Taiwan. J Headache Pain (2012) 0.95
ACE D/I polymorphism, migraine, and cardiovascular disease in women. Neurology (2009) 0.94
Disclosing conflicts of interest in German publications concerning health services research. BMC Health Serv Res (2007) 0.93
Migraine-associated risks and comorbidity. J Neurol (2008) 0.92
Association of benign recurrent vertigo and migraine in 208 patients. Cephalalgia (2009) 0.92
Metabolic syndrome and migraine. Front Neurol (2012) 0.91
Migraine and subsequent risk of breast cancer: a prospective cohort study. Cancer Causes Control (2012) 0.91
Patent foramen ovale, ischemic stroke and migraine: systematic review and stratified meta-analysis of association studies. Neuroepidemiology (2012) 0.90
Migraine and risk of cardiovascular disease in women: prospective cohort study. BMJ (2016) 0.89
A candidate gene association study of 77 polymorphisms in migraine. J Pain (2009) 0.88
A genome-wide analysis of 'Bounty' descendants implicates several novel variants in migraine susceptibility. Neurogenetics (2012) 0.88
Migraine and cognitive decline in the population-based EVA study. Cephalalgia (2011) 0.87
Hormonal contraceptive options for women with headache: a review of the evidence. Rev Obstet Gynecol (2010) 0.86
Neurological disorders and inflammatory bowel diseases. World J Gastroenterol (2014) 0.86
Migraine and cognitive decline among women: prospective cohort study. BMJ (2012) 0.85
Diabetes and its chronic complications in the She ethnic minority group of China. Diabetes Technol Ther (2012) 0.85
Endothelial function in migraine: a cross-sectional study. BMC Neurol (2010) 0.85
Associations between lipid levels and migraine: cross-sectional analysis in the epidemiology of vascular ageing study. Cephalalgia (2011) 0.85
Migraine, migraine features, and cardiovascular disease. Headache (2010) 0.85
Migraine features, associated symptoms and triggers: a principal component analysis in the Women's Health Study. Cephalalgia (2011) 0.85
The migraine association with cardiac anomalies, cardiovascular disease, and stroke. Neurol Clin (2009) 0.84
Effect of Yoga on migraine: A comprehensive study using clinical profile and cardiac autonomic functions. Int J Yoga (2014) 0.84
MTHFR 677C->T and ACE D/I polymorphisms and migraine attack frequency in women. Cephalalgia (2010) 0.84
Unreported financial disclosures in a study of migraine and cardiovascular disease. JAMA (2006) 0.82
Polymorphisms in the renin-angiotensin system and migraine in women. Headache (2008) 0.82
Migraine and breast cancer risk: a prospective cohort study and meta-analysis. J Natl Cancer Inst (2014) 0.82
Trimester-specific blood pressure levels and hypertensive disorders among pregnant migraineurs. Headache (2011) 0.82
Migraine and cerebral infarction in young people. Neurol Sci (2009) 0.82
Association of Migraine and Sleep-Related Breathing Disorder: A Population-Based Cohort Study. Medicine (Baltimore) (2015) 0.81
Genes and primary headaches: discovering new potential therapeutic targets. J Headache Pain (2013) 0.80
Migraine and cardiovascular disease. JAMA (2006) 0.80
Migraine and metabolism. Neurol Sci (2012) 0.80
Simvastatin and vitamin D for migraine prevention: A randomized, controlled trial. Ann Neurol (2015) 0.80
Hyperlipidemia in migraine: Is it more frequent in migraineurs? Iran J Neurol (2011) 0.80
Sex-related differences in migraine. Neurol Sci (2014) 0.79
Migraine, depression, and brain volume: the AGES-Reykjavik Study. Neurology (2013) 0.79
Clinical evaluation of patients with migraine induced stroke in mashhad, iran. ARYA Atheroscler (2010) 0.79
Genetic determinants of cardiovascular events among women with migraine: a genome-wide association study. PLoS One (2011) 0.79
Funding of research on headache disorders by the National Institutes of Health. Headache (2009) 0.79
Migraine and cardiovascular disease in women and the role of aspirin: subgroup analyses in the Women's Health Study. Cephalalgia (2011) 0.79
Headache management: pharmacological approaches. Pract Neurol (2015) 0.78
Migraine and risk of incident diabetes in women: a prospective study. Cephalalgia (2012) 0.78
Metabolic syndrome in migraine headache: A case-control study. J Res Med Sci (2014) 0.78
Migraine and cardiovascular disease: is there a link? Nat Clin Pract Neurol (2007) 0.77
Migraine and cerebrovascular risk. Neurol Sci (2010) 0.77
The Face of Chronic Migraine Which Has Started to be Clarified. Noro Psikiyatr Ars (2013) 0.77
[Pathophysiology of migraine and clinical implications]. Schmerz (2008) 0.77
Haplotype analysis of the folate-related genes MTHFR, MTRR, and MTR and migraine with aura. Cephalalgia (2013) 0.77
Migraine, cerebrovascular disease and the metabolic syndrome. Ann Indian Acad Neurol (2012) 0.77
Lack of association between the MTHFR C677T variant and migraine with aura in an older population: could selective survival play a role? Cephalalgia (2012) 0.77
Migraine: migraine with aura increases the risk of stroke. Nat Rev Neurol (2010) 0.77
Migraine as a risk factor for young patients with ischemic stroke: a case-control study. Neurol Sci (2017) 0.76
Neurovascular pains: implications of migraine for the oral and maxillofacial surgeon. Oral Maxillofac Surg Clin North Am (2008) 0.76
Migraine with aura and patent foramen ovale: myth or reality? Neurol Sci (2015) 0.76
Migraine and hemorrhagic stroke: data from general practice. J Headache Pain (2015) 0.76
Migraine attack restores the response of vascular smooth muscle cells to nitric oxide but not to norepinephrine. World J Cardiol (2013) 0.76
[Current diagnosis and treatment of migraine]. Schmerz (2008) 0.76
Migraine and cardiovascular diseases. Neurol Sci (2012) 0.76
Migraine and Stroke: What's the Link? What to Do? Curr Neurol Neurosci Rep (2017) 0.75
Diagnostic value of nitroglycerin-induced headache as a negative predictor of coronary atherosclerosis. Chonnam Med J (2011) 0.75
Cardiovascular disease risk in women with migraine. J Headache Pain (2013) 0.75
Headache in the presentation of noncephalic acute illness. J Neurosci Rural Pract (2016) 0.75
Fasting lipid and lipoproteins concentrations in pregnant women with a history of migraine. Headache (2015) 0.75
Association between migraine and cardiovascular disease in women. JAMA (2006) 0.75
Comorbidity of Migraine. Noro Psikiyatr Ars (2013) 0.75
Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med (2009) 39.97
A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women. N Engl J Med (2005) 17.32
Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med (2002) 16.23
Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds Risk Score. JAMA (2007) 15.32
Assessing the performance of prediction models: a framework for traditional and novel measures. Epidemiology (2010) 14.07
Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA (2008) 13.35
Vitamin E in the primary prevention of cardiovascular disease and cancer: the Women's Health Study: a randomized controlled trial. JAMA (2005) 12.09
Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study. Lancet (2010) 11.25
Vitamin E and the risk of prostate cancer: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA (2011) 11.02
Apixaban in patients with atrial fibrillation. N Engl J Med (2011) 9.97
Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women. JAMA (2007) 9.68
Stent-retriever thrombectomy after intravenous t-PA vs. t-PA alone in stroke. N Engl J Med (2015) 9.58
Statins: new American guidelines for prevention of cardiovascular disease. Lancet (2013) 9.56
Low-dose aspirin in the primary prevention of cancer: the Women's Health Study: a randomized controlled trial. JAMA (2005) 9.03
Vitamins E and C in the prevention of cardiovascular disease in men: the Physicians' Health Study II randomized controlled trial. JAMA (2008) 8.32
C-reactive protein and parental history improve global cardiovascular risk prediction: the Reynolds Risk Score for men. Circulation (2008) 7.33
Telmisartan to prevent recurrent stroke and cardiovascular events. N Engl J Med (2008) 7.25
C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14 719 initially healthy American women. Circulation (2003) 6.99
Risk of bleeding with 2 doses of dabigatran compared with warfarin in older and younger patients with atrial fibrillation: an analysis of the randomized evaluation of long-term anticoagulant therapy (RE-LY) trial. Circulation (2011) 6.48
Effects of lowering homocysteine levels with B vitamins on cardiovascular disease, cancer, and cause-specific mortality: Meta-analysis of 8 randomized trials involving 37 485 individuals. Arch Intern Med (2010) 6.48
C-reactive protein, fibrinogen, and cardiovascular disease prediction. N Engl J Med (2012) 6.39
Soft drink consumption and risk of developing cardiometabolic risk factors and the metabolic syndrome in middle-aged adults in the community. Circulation (2007) 6.34
Relations of serum phosphorus and calcium levels to the incidence of cardiovascular disease in the community. Arch Intern Med (2007) 6.29
Results of multivariable logistic regression, propensity matching, propensity adjustment, and propensity-based weighting under conditions of nonuniform effect. Am J Epidemiol (2005) 6.20
Sex hormone-binding globulin and risk of type 2 diabetes in women and men. N Engl J Med (2009) 6.16
Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke. N Engl J Med (2008) 6.08
Cardiovascular disease risk prediction with and without knowledge of genetic variation at chromosome 9p21.3. Ann Intern Med (2009) 6.00
Hemoglobin A1c predicts diabetes but not cardiovascular disease in nondiabetic women. Am J Med (2007) 5.95
C-reactive protein and the risk of developing hypertension. JAMA (2003) 5.75
Non-HDL cholesterol, apolipoproteins A-I and B100, standard lipid measures, lipid ratios, and CRP as risk factors for cardiovascular disease in women. JAMA (2005) 5.74
The effect of including C-reactive protein in cardiovascular risk prediction models for women. Ann Intern Med (2006) 5.69
Laboratory-based versus non-laboratory-based method for assessment of cardiovascular disease risk: the NHANES I Follow-up Study cohort. Lancet (2008) 5.49
Cryptogenic stroke and underlying atrial fibrillation. N Engl J Med (2014) 5.44
NXY-059 for acute ischemic stroke. N Engl J Med (2006) 5.32
Measures of obesity and cardiovascular risk among men and women. J Am Coll Cardiol (2008) 5.28
Physical activity and weight gain prevention. JAMA (2010) 5.27
Multivitamins in the prevention of cancer in men: the Physicians' Health Study II randomized controlled trial. JAMA (2012) 5.25
Genome-wide association study identifies variants in the ABO locus associated with susceptibility to pancreatic cancer. Nat Genet (2009) 5.14
Vitamins E and C in the prevention of prostate and total cancer in men: the Physicians' Health Study II randomized controlled trial. JAMA (2008) 5.13
Adherence to a DASH-style diet and risk of coronary heart disease and stroke in women. Arch Intern Med (2008) 4.98
Migraine and cardiovascular disease: systematic review and meta-analysis. BMJ (2009) 4.98
Inactivating mutations in NPC1L1 and protection from coronary heart disease. N Engl J Med (2014) 4.94
A genome-wide association study identifies pancreatic cancer susceptibility loci on chromosomes 13q22.1, 1q32.1 and 5p15.33. Nat Genet (2010) 4.89
Risk of death and cardiovascular events in initially healthy women with new-onset atrial fibrillation. JAMA (2011) 4.73
Pharmacogenetic study of statin therapy and cholesterol reduction. JAMA (2004) 4.47
Association between a literature-based genetic risk score and cardiovascular events in women. JAMA (2010) 4.46
Prevalence of dry eye syndrome among US women. Am J Ophthalmol (2003) 4.46
Rationale, design, and methodology of the Women's Genome Health Study: a genome-wide association study of more than 25,000 initially healthy american women. Clin Chem (2007) 4.45
Multivitamins in the prevention of cardiovascular disease in men: the Physicians' Health Study II randomized controlled trial. JAMA (2012) 4.40
Calcitonin gene-related peptide receptor antagonist BIBN 4096 BS for the acute treatment of migraine. N Engl J Med (2004) 4.39
OnabotulinumtoxinA for treatment of chronic migraine: pooled results from the double-blind, randomized, placebo-controlled phases of the PREEMPT clinical program. Headache (2010) 4.37
Loci related to metabolic-syndrome pathways including LEPR,HNF1A, IL6R, and GCKR associate with plasma C-reactive protein: the Women's Genome Health Study. Am J Hum Genet (2008) 4.31
A comprehensive care management program to prevent chronic obstructive pulmonary disease hospitalizations: a randomized, controlled trial. Ann Intern Med (2012) 4.10
Lipoprotein particle profiles by nuclear magnetic resonance compared with standard lipids and apolipoproteins in predicting incident cardiovascular disease in women. Circulation (2009) 3.93
New models for large prospective studies: is there a better way? Am J Epidemiol (2012) 3.85
Childhood blood pressure trends and risk factors for high blood pressure: the NHANES experience 1988-2008. Hypertension (2013) 3.81
Genome-wide association studies identify four ER negative-specific breast cancer risk loci. Nat Genet (2013) 3.81
NXY-059 for the treatment of acute ischemic stroke. N Engl J Med (2007) 3.70
Prognostication after cardiac arrest and hypothermia: a prospective study. Ann Neurol (2010) 3.70
Detectable clonal mosaicism and its relationship to aging and cancer. Nat Genet (2012) 3.69
Meta-analysis of genome-wide association studies in >80 000 subjects identifies multiple loci for C-reactive protein levels. Circulation (2011) 3.68
Prediagnostic body-mass index, plasma C-peptide concentration, and prostate cancer-specific mortality in men with prostate cancer: a long-term survival analysis. Lancet Oncol (2008) 3.62
Decision making in advanced heart failure: a scientific statement from the American Heart Association. Circulation (2012) 3.61
Ximelagatran vs warfarin for stroke prevention in patients with nonvalvular atrial fibrillation: a randomized trial. JAMA (2005) 3.54
Comparison of self-report, hospital discharge codes, and adjudication of cardiovascular events in the Women's Health Initiative. Am J Epidemiol (2004) 3.53
Standards for epidemiologic studies and surveillance of epilepsy. Epilepsia (2011) 3.48
Methods for pooling results of epidemiologic studies: the Pooling Project of Prospective Studies of Diet and Cancer. Am J Epidemiol (2006) 3.41
The association between statins and cancer incidence in a veterans population. J Natl Cancer Inst (2008) 3.40
Thirty new loci for age at menarche identified by a meta-analysis of genome-wide association studies. Nat Genet (2010) 3.37
A common variant at the TERT-CLPTM1L locus is associated with estrogen receptor-negative breast cancer. Nat Genet (2011) 3.37
A randomized factorial trial of vitamins C and E and beta carotene in the secondary prevention of cardiovascular events in women: results from the Women's Antioxidant Cardiovascular Study. Arch Intern Med (2007) 3.37